Overview

Erythropoietin Effects After Traumatic Brain Injury

Status:
Withdrawn
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
To determine if the early administration of erythropoietin to patients sustaining traumatic brain injury will reduce secondary brain injury.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Epoetin Alfa